STOCK TITAN
  1. Home
  2. Sec-filings
  3. AMAL
  4. [Form 4] Amalgamated Financial Corp. Insider Trading Activity

[Form 4] Amalgamated Financial Corp. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Amalgamated Financial Corp. (AMAL) director reported multiple equity transactions on Form 4. On 10/30/2025, the director exercised stock options for 4,820 shares at $12, 7,020 shares at $13.75, and 6,560 shares at $14.65, with share withholding for taxes of 2,381, 3,468, and 3,240 shares at $27.5575. Sales included 300 shares at $27.49 on 08/07/2025 and 8,949 shares at a weighted average price of $27.3354 on 10/31/2025. On 11/01/2025, the director received 2,568 restricted stock units that vest immediately. Beneficial ownership following these transactions was 24,844 shares, held directly.

Footnote (1) states the 10/31 sale price reflects multiple trades between $27.06 and $27.63.

Positive

  • None.

Negative

  • None.

Insights

Insider option exercises and sales; company ends stock option program and grants immediate-vest RSUs.

This Form 4 shows a director of Amalgamated Financial Corp. (AMAL) exercising legacy non-qualified stock options and selling shares, with tax-withholding entries. Notably, it discloses the Company’s termination of its stock option program and a compensatory grant of 2,568 restricted stock units that vest immediately upon grant on 11/01/2025.

Mechanically: options with strikes of $12, $13.75, and $14.65 were exercised on 10/30/2025 (codes “M”), followed by share dispositions for taxes (code “F” at $27.5575) and open market sales (code “S,” including 8,949 shares at a weighted average of $27.3354). After these entries and the RSU award, reported direct ownership changed across the sequence, ending with 24,844 shares.

Why it matters: ending the stock option program signals a shift in equity compensation design toward full-value awards (RSUs). That changes dilution patterns and pay mix. The weighted-average sale disclosure indicates standard compliance; the footnote commits to provide detailed trade breakdowns upon request. Items to watch: future director and officer grants post-termination, any board or plan amendments, and upcoming Section 16 reports around year-end 2025 that show if RSUs replace options across more insiders.

Insider Fox Lynne P.
Role Director
Sold 9,249 shs ($253K)
Type Security Shares Price Value
Grant/Award Common Stock 2,568 $0.00 --
Sale Common Stock 8,949 $27.3354 $245K
Exercise Non-Qualified Stock Option (right to buy) 4,820 $0.00 --
Exercise Non-Qualified Stock Option (right to buy) 7,020 $0.00 --
Exercise Non-Qualified Stock Option (right to buy) 6,560 $0.00 --
Exercise Common Stock 4,820 $12.00 $58K
Tax Withholding Common Stock 2,381 $27.5575 $66K
Exercise Common Stock 7,020 $13.75 $97K
Tax Withholding Common Stock 3,468 $27.5575 $96K
Exercise Common Stock 6,560 $14.65 $96K
Tax Withholding Common Stock 3,240 $27.5575 $89K
Sale Common Stock 300 $27.49 $8K
Holdings After Transaction: Common Stock — 24,844 shares (Direct); Non-Qualified Stock Option (right to buy) — 0 shares (Direct)
Footnotes (1)
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.06 - $27.63 . The reporting person undertakes to provide to AMAL, any security holder of AMAL, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. The reported transaction involved the reporting person's receipt of a grant of 2,568 restricted stock units. The restricted stock units vest immediately upon grant, in consideration of the Company's termination of the stock option program and the Director's early exercise of all outstanding and vested stock options on October 30, 2025.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Fox Lynne P.
(Last) (First) (Middle)
275 7TH AVE
(Street)
NEW YORK NY 10001
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Amalgamated Financial Corp. [ AMAL ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/07/2025 S 300 D $27.49 21,914 D
Common Stock 10/30/2025 M 4,820 A $12 26,734 D
Common Stock 10/30/2025 F 2,381 D $27.5575 24,353 D
Common Stock 10/30/2025 M 7,020 A $13.75 31,373 D
Common Stock 10/30/2025 F 3,468 D $27.5575 27,905 D
Common Stock 10/30/2025 M 6,560 A $14.65 34,465 D
Common Stock 10/30/2025 F 3,240 D $27.5575 31,225 D
Common Stock 10/31/2025 S 8,949 D $27.3354(1) 22,276 D
Common Stock 11/01/2025 A 2,568 A $0 24,844(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy) $12 10/30/2025 M 4,820 01/01/2016 01/01/2026 Common Stock 4,820 $0 0 D
Non-Qualified Stock Option (right to buy) $13.75 10/30/2025 M 7,020 01/01/2017 01/01/2027 Common Stock 7,020 $0 0 D
Non-Qualified Stock Option (right to buy) $14.65 10/30/2025 M 6,560 01/01/2018 01/01/2028 Common Stock 6,560 $0 0 D
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.06 - $27.63 . The reporting person undertakes to provide to AMAL, any security holder of AMAL, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
2. The reported transaction involved the reporting person's receipt of a grant of 2,568 restricted stock units. The restricted stock units vest immediately upon grant, in consideration of the Company's termination of the stock option program and the Director's early exercise of all outstanding and vested stock options on October 30, 2025.
Remarks:
/s/Lynne Fox 11/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR